125 related articles for article (PubMed ID: 10026448)
1. Extended pancreatectomy and liver perfusion chemotherapy for resectable adenocarcinoma of the pancreas.
Ishikawa O; Ohhigashi H; Sasaki Y; Furukawa H; Imaoka S
Digestion; 1999; 60 Suppl 1():135-8. PubMed ID: 10026448
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapies in extended pancreatectomy for ductal adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Masao K; Kabuto T; Furukawa H; Imaoka S
Hepatogastroenterology; 1998; 45(21):644-50. PubMed ID: 9684110
[TBL] [Abstract][Full Text] [Related]
3. Radical resection for pancreatic cancer.
Ishikawa O; Ohigashi H; Yamada T; Sasaki Y; Imaoka S; Nakaizumi A; Uehara H; Tanaka S; Takenaka A
Acta Gastroenterol Belg; 2002; 65(3):166-70. PubMed ID: 12420609
[TBL] [Abstract][Full Text] [Related]
4. Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas.
Ishikawa O; Ohigashi H; Sasaki Y; Furukawa H; Kabuto T; Kameyama M; Nakamori S; Hiratsuka M; Imaoka S
Am J Surg; 1994 Oct; 168(4):361-4. PubMed ID: 7943597
[TBL] [Abstract][Full Text] [Related]
5. The role of adjuvant therapy for pancreatic cancer.
Takeda S; Inoue S; Kaneko T; Harada A; Nakao A
Hepatogastroenterology; 2001; 48(40):953-6. PubMed ID: 11490847
[TBL] [Abstract][Full Text] [Related]
6. Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer.
Ishikawa O; Ohigashi H; Imaoka S; Sasaki Y; Kameyama M; Nakamori S; Kabuto T; Furukawa H
Hepatogastroenterology; 1997; 44(18):1541-6. PubMed ID: 9427019
[TBL] [Abstract][Full Text] [Related]
7. Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas.
Ishikawa O
Hepatogastroenterology; 1996; 43(8):320-5. PubMed ID: 8714223
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficacy of combination therapy with preoperative and postoperative chemoradiation, extended pancreatectomy, and postoperative liver perfusion chemotherapy for locally advanced cancers of the pancreatic head.
Ohigashi H; Ishikawa O; Eguchi H; Sasaki Y; Yamada T; Noura S; Murata K; Takachi K; Miyashiro I; Doki Y; Imaoka S; Kasugai T; Nishiyama K
Ann Surg Oncol; 2005 Aug; 12(8):629-36. PubMed ID: 15968497
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant therapies in combination with pancreatectomy for carcinoma of the pancreas].
Ishikawa O; Ohigashi H; Sasaki Y; Furukawa H; Kabuto T; Imaoka S; Iwanaga T; Nakaizumi A; Uehara H; Matayoshi Y
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1635-41. PubMed ID: 8886033
[TBL] [Abstract][Full Text] [Related]
10. Strategies to improve local control of resected pancreas adenocarcinoma.
Sugarbaker PH
Surg Oncol; 2017 Mar; 26(1):63-70. PubMed ID: 28317586
[TBL] [Abstract][Full Text] [Related]
11. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
[TBL] [Abstract][Full Text] [Related]
12. What constitutes curative pancreatectomy for adenocarcinoma of the pancreas?
Ishikawa O
Hepatogastroenterology; 1993 Oct; 40(5):414-7. PubMed ID: 8270229
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study.
Jang JY; Kang JS; Han Y; Heo JS; Choi SH; Choi DW; Park SJ; Han SS; Yoon DS; Park JS; Yu HC; Kang KJ; Kim SG; Lee H; Kwon W; Yoon YS; Han HS; Kim SW
J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):426-433. PubMed ID: 28514000
[TBL] [Abstract][Full Text] [Related]
14. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma.
Imamura M; Hosotani R; Kogire M
Digestion; 1999; 60 Suppl 1():126-9. PubMed ID: 10026446
[TBL] [Abstract][Full Text] [Related]
15. Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma.
Tani M; Kawai M; Miyazawa M; Hirono S; Ina S; Nishioka R; Fujita Y; Uchiyama K; Yamaue H
Langenbecks Arch Surg; 2009 Mar; 394(2):249-53. PubMed ID: 18343944
[TBL] [Abstract][Full Text] [Related]
16. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
[TBL] [Abstract][Full Text] [Related]
17. Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection.
Yamaue H; Tani M; Onishi H; Kinoshita H; Nakamori M; Yokoyama S; Iwahashi M; Uchiyama K
Pancreas; 2002 Nov; 25(4):366-72. PubMed ID: 12409831
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
20. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.
Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S
Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
